Life Sciences Third-Party Risk Management: A Strategic Approach

An Expert Panel Webinar
Presented by Grant Thornton & Opus

  • May 11, 2018
  • Webinar Recording

Lisa WalkushLisa Walkush
National Life Sciences Industry Sector Leader
Grant Thornton LLP

Vikrant RaiVikrant Rai
Director, Cyber Risk
Grant Thornton LLP

Adam SchrockAdam Schrock
Managing Director, Risk Advisory Services
Grant Thornton LLP

Mark DelucaMark DeLuca
Senior Vice President, Worldwide Sales
Opus

Panelist Bios

Third parties are one of the biggest challenges facing life sciences companies today – from pharmaceuticals to medical device companies to healthcare providers and beyond.

They’re a critical business driver – from vendors and suppliers to CROs, CMOs and other intermediaries – but also introduce significant risks, from corruption to data breaches. Your third party is an extension of your business, and you’re responsible for their actions.

Join an expert panel of experts from Grant Thornton and Opus as we discuss how life sciences professionals can collaborate to address multiple challenges through combined solutions. Our panelists will discuss:

  • Why reliance on third parties is increasing – the role of outsourcing today and tomorrow
  • Best practices from other industries – what life sciences can learn
  • A governance structure that works – people, process and technology
  • How to reduce costs, risks and effort by combining platforms
  • The risks of not sharing data across silos
  • Addressing the challenges – who’s the buyer? Who are the stakeholders?

 

Watch the Webinar Recording